BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34959332)

  • 1. Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery.
    Berillo D; Zharkinbekov Z; Kim Y; Raziyeva K; Temirkhanova K; Saparov A
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Polymers in Nasal Drug Delivery.
    Chonkar A; Nayak U; Udupa N
    Indian J Pharm Sci; 2015; 77(4):367-75. PubMed ID: 26664051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel versatile flow-donor chamber as biorelevant ex-vivo test assessing oral mucoadhesive formulations.
    Gidvall S; Björklund S; Feiler A; Dahlström B; Rönn R; Engblom J; Valetti S
    Eur J Pharm Sci; 2021 Nov; 166():105983. PubMed ID: 34461276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in polymeric non-invasive insulin delivery.
    Sabbagh F; Muhamad II; Niazmand R; Dikshit PK; Kim BS
    Int J Biol Macromol; 2022 Apr; 203():222-243. PubMed ID: 35101478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures.
    Jijie R; Barras A; Boukherroub R; Szunerits S
    J Mater Chem B; 2017 Nov; 5(44):8653-8675. PubMed ID: 32264260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives.
    Sofi HS; Abdal-Hay A; Ivanovski S; Zhang YS; Sheikh FA
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110756. PubMed ID: 32279775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
    Rapoport AM; Freitag F; Pearlman SH
    CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
    Baviskar DT; Parik VB; Jain DJ
    PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
    Mignani S; El Kazzouli S; Bousmina M; Majoral JP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buccoadhesive drug delivery systems--extensive review on recent patents.
    Pathan SA; Iqbal Z; Sahani JK; Talegaonkar S; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2008; 2(2):177-88. PubMed ID: 19075906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermoresponsive mucoadhesive hybrid gels in advanced drug delivery systems.
    Mfoafo K; Omidi Y; Omidian H
    Int J Pharm; 2023 Apr; 636():122799. PubMed ID: 36914019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
    Zhang H; Zhang J; Streisand JB
    Clin Pharmacokinet; 2002; 41(9):661-80. PubMed ID: 12126458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palatal mucosa as a route for systemic drug delivery: A review.
    Shakya P; Madhav NV; Shakya AK; Singh K
    J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of non-intravenous formulations of fentanyl.
    Lötsch J; Walter C; Parnham MJ; Oertel BG; Geisslinger G
    Clin Pharmacokinet; 2013 Jan; 52(1):23-36. PubMed ID: 23100195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery.
    Mahlumba P; Choonara YE; Kumar P; du Toit LC; Pillay V
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Responsive Microarray Patches for Transdermal Drug Delivery and Biological Monitoring.
    Zhao L; Zhang C; Abu-Ershaid JM; Li M; Li Y; Naser Y; Dai X; Abbate MTA; Donnelly RF
    Adv Healthc Mater; 2021 Oct; 10(20):e2100996. PubMed ID: 34449129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
    Olsson Gisleskog PO; Perez Ruixo JJ; Westin Å; Hansson AC; Soons PA
    Clin Pharmacokinet; 2021 Apr; 60(4):541-561. PubMed ID: 33354734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orotransmucosal drug delivery systems: a review.
    Madhav NV; Shakya AK; Shakya P; Singh K
    J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.